Archer Materials Receives US Patent Related to Biochip Project; Shares Rise Almost 11%

MT Newswires Live
Jan 22

Archer Materials (ASX:AXE) said it was granted a US patent for its biochip project, representing the design and work done on the development of the biosensing chip for graphene complexes and their compositions that can be used in biomolecular sensing, according to a Wednesday Australian bourse filing.

It has been researching new methods to attach inorganic molecules to graphene, a form of carbon.

The firm considers the US a critical strategic jurisdiction to protect and potentially commercialize its biochip intellectual property.

The firm's executive chair, Greg English, said that the US is a key market "due to the size of the market and the rate of chronic kidney disease in the country."

The firm's shares rose almost 11% in recent trading on Wednesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10